- Where is ERAS in the management of advanced ovarian cancer?: between myths and truths
-
Noh JJ, Lee YY
- KMID: 2537915
- J Gynecol Oncol.
- 2022 Sep;33(5):e79.
- doi: 10.3802/jgo.2022.33.e79
-
- CITED
-
- Close
- SHARE
-
- Close
- Report from the 36th Annual Meeting of the Korean Society of Gynecologic Oncology (KSGO)
-
Kim JH, Noh JJ, Eoh KJ, Kim YT
- KMID: 2526130
- J Gynecol Oncol.
- 2021 Jul;32(4):e75.
- doi: 10.3802/jgo.2021.32.e75
-
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic imaging analysis of the impacted mesiodens
-
Noh JJ, Choi BR, Jeong HS, Huh KH, Yi WJ, Heo MS, Lee SS, Choi SC
- KMID: 1456401
- Korean J Oral Maxillofac Radiol.
- 2010 Jun;40(2):69-74.
PURPOSE: The research was performed to predict the three dimensional relationship between the impacted mesiodens and the maxillary central incisors and the proximity with the anatomic structures by comparing their... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
-
Shin W, Noh JJ, Seo SS, Kang S, Choi CH, Park SY, Kim BG, Lim MC
- KMID: 2507805
- Yonsei Med J.
- 2020 Nov;61(11):935-941.
- doi: 10.3349/ymj.2020.61.11.935
Purpose: Salvage second-line chemotherapy is usually recommended for patients with advanced epithelial ovarian cancer (AEOC) who develop progressive disease (PD) after neoadjuvant chemotherapy (NAC). Herein, we investigated the role of... -
- CITED
-
- Close
- SHARE
-
- Close
- Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers
-
Noh JJ, Kim MK, Choi MC, Lee JW, Park H, Jung SG, Joo WD, Song SH, Lee C
- KMID: 2534199
- Cancer Res Treat.
- 2022 Oct;54(4):1200-1208.
- doi: 10.4143/crt.2021.828
Purpose This study was to investigate the frequency of mismatch repair deficiency/high microsatellite instability (MMRd/MSI-H) in gynecologic malignancies and the efficacy of immune checkpoint inhibitors (ICIs) in patients with recurrent gynecologic... -
- CITED
-
- Close
- SHARE
-
- Close
